Stock NAVA NAVAMEDIC ASA
Add to a list
To use this feature you must be a member
Log inSign up

Company Navamedic ASA

Equities

NAVA

NO0010205966

Pharmaceuticals

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-05-03 EDT 		5-day change 1st Jan Change
32.6 NOK -2.98% Intraday chart for Navamedic ASA -4.12% -11.17%
04-30 Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-13 Ingerø Reiten Investment Divests Navamedic Stake in NOK95 Million Deal MT

Business Summary

Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.

Number of employees: 45

Sales per Business

NOK in Million2021Weight2022Weight Delta
Specialty Pharma
41.6 %
112 40.3 % 159 41.6 % +41.76%
Branded Generics
23.4 %
71 25.4 % 90 23.4 % +26.80%
Consumer Health
20.8 %
43 15.5 % 80 20.8 % +84.38%
Medical Nutrition
14.1 %
52 18.7 % 54 14.1 % +3.71%

Sales per region

NOK in Million2021Weight2022Weight Delta
Norway
52.0 %
138 49.6 % 199 52.0 % +44.07%
Sweden
25.3 %
60 21.5 % 97 25.3 % +61.57%
Other Countries
10.6 %
39 14.0 % 40 10.6 % +3.47%
Denmark
7.4 %
28 9.9 % 28 7.4 % +1.94%
Finland
4.7 %
14 5.0 % 18 4.7 % +29.64%

Managers

Managers TitleAgeSince
Kathrine Elisabeth Andreassen CEO
 Chief Executive Officer 58 18-05-31
Lars Hjarrand DFI
 Director of Finance/CFO 51 19-12-08
Astrid T. Bratvedt CTO
 Chief Tech/Sci/R&D Officer - 18-12-31
Ole Henrik Eriksen COO
 Chief Operating Officer 65 18-12-31
Alexander Lidmejer PRN
 Corporate Officer/Principal 43 09-12-31

Members of the board

Members of the board TitleAgeSince
Narve Reiten BRD
 Director/Board Member 63 -
Terje Bakken CHM
 Chairman 58 18-12-30
Jostein Davidsen BRD
 Director/Board Member 65 17-01-15
Kathrine Elisabeth Andreassen CEO
 Chief Executive Officer 58 18-05-31
Annika Kollén BRD
 Director/Board Member - 21-06-02
Åsa Kornfeld BRD
 Director/Board Member - 23-05-31
Edmée Steenken BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,353,777 10,121,690 ( 58.33 %) 0 58.33 %

Shareholders

NameEquities%Valuation
Narve Reiten
20.53 %
3,563,042 20.53 % 12 M kr
Nordea Investment Management AB
9.164 %
1,590,182 9.164 % 5 M kr
Futur Pension Försäkringsaktiebolag
6.612 %
1,147,299 6.612 % 4 M kr
Kathrine Elisabeth Andreassen
3.842 %
666,668 3.842 % 2 M kr
Fondita Fund Management Co. Ltd.
3.746 %
650,000 3.746 % 2 M kr
Tranbergkollen Invest AS
3.025 %
525,000 3.025 % 2 M kr
Leikerane AS
2.881 %
500,000 2.881 % 2 M kr
First Fondene AS
2.530 %
439,015 2.530 % 1 M kr
Ginko AS
2.305 %
400,000 2.305 % 1 M kr
Aktia Fondbolag Ab
2.305 %
400,000 2.305 % 1 M kr

Company contact information

Navamedic ASA

Henrik Ibsensgate 100

0255, Oslo

+47 67 11 25 40

http://www.navamedic.com
address Navamedic ASA(NAVA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Navamedic ASA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
32.6 NOK
Average target price
49 NOK
Spread / Average Target
+50.31%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
NAVAMEDIC ASA Stock Navamedic ASA
-11.17% 52.42M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NAVA Stock
  4. Company Navamedic ASA